JOHNSON & JOHNSON

JNJ · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $580.4B · 140,800 employees
150
SEC Filings
$223.51
Close 2026-06-01
5
Transcripts
140,800
Employees

Business Summary

Johnson & Johnson is a global healthcare holding company with approximately 138,200 employees operating in virtually all countries. It is organized into two segments: Innovative Medicine (pharmaceuticals across oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular/metabolism) and MedTech (cardiovascular, orthopaedics, surgery, and vision products). Key products include DARZALEX, STELARA, TREMFYA, CARVYKTI, SPRAVATO, XARELTO, and ACUVUE contact lenses.

Latest Stock Quote

JNJ 2026-06-01 $223.51 O:$223.2 H:$224.44 L:$220.84 Vol:8.0M VWAP:$222.9641
origin leaf: d34e54c6fc01d2bd2118a3540a779810909eb8527fceac841ac1c61b3c2fc9ee

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key People

NameRolePeriod
MattAnalyst, Miksic Barclays Services Corp? – present

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionJNJdiscussed Artificial Intelligence
topic_mentionJNJdiscussed Artificial Intelligence
topic_mentionJNJdiscussed Artificial Intelligence
topic_mentionJNJdiscussed Artificial Intelligence
topic_mentionJNJdiscussed Blockchain & Crypto
topic_mentionJNJdiscussed Networking
topic_mentionJNJdiscussed Robotics
topic_mentionJNJdiscussed Supply Chain
topic_mentionJNJdiscussed Regulation
topic_mentionJNJdiscussed Sovereign & Government
topic_mentionJNJdiscussed Gaming
topic_mentionJNJdiscussed Automotive
topic_mentionJNJdiscussed Healthcare & Bio
topic_mentionJNJdiscussed Platform & Ecosystem
guidanceJNJguided guidance for 202 6 with estimated reported sale s of $100.5 Billion
outlookJNJstated we believe health is everything
topic_mentionJNJdiscussed Artificial IntelligenceQ4 FY2025
topic_mentionJNJdiscussed Blockchain & CryptoQ4 FY2025
topic_mentionJNJdiscussed RoboticsQ4 FY2025
topic_mentionJNJdiscussed Supply ChainQ4 FY2025

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-280000200406-26-000016EDGAR70K words
2025-02-132024-12-290000200406-25-000038EDGAR—
2024-02-162023-12-310000200406-24-000013EDGAR—
2023-02-162023-01-010000200406-23-000016EDGAR—
2022-02-172022-01-020000200406-22-000022EDGAR—
2021-02-222021-01-030000200406-21-000008EDGAR—
2020-02-182019-12-290000200406-20-000010EDGAR—
2019-02-202018-12-300000200406-19-000009EDGAR—
2018-02-212017-12-310000200406-18-000005EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-04-222026-03-290000200406-26-000087EDGAR—
2025-10-222025-09-280000200406-25-000209EDGAR35K words
2025-07-242025-06-290000200406-25-000178EDGAR—
2025-04-232025-03-300000200406-25-000119EDGAR—
2024-10-232024-09-290000200406-24-000096EDGAR—
2024-07-252024-06-300000200406-24-000075EDGAR—
2024-05-012024-03-310000200406-24-000049EDGAR—
2023-10-272023-10-010000200406-23-000102EDGAR—
2023-07-312023-07-020000200406-23-000082EDGAR—
2023-04-282023-04-020000200406-23-000056EDGAR—
2022-10-272022-10-020000200406-22-000086EDGAR—
2022-07-292022-07-030000200406-22-000071EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-280000200406-26-000089EDGAR—
2026-04-140000200406-26-000076EDGAR7K words
2026-01-210000200406-26-000002EDGAR15K words
2025-10-140000200406-25-000201EDGAR—
2025-09-090000200406-25-000190EDGAR—
2025-07-160000200406-25-000170EDGAR—
2025-06-100000200406-25-000152EDGAR—
2025-04-300000200406-25-000141EDGAR—
2025-04-150000200406-25-000110EDGAR—
2025-04-030000200406-25-000106EDGAR—

150 total filings indexed. 119 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— JNJ Earnings Call Transcript
—Q4 FY2025JNJ Q4 FY2025 Earnings Call Transcript
— JNJ Earnings Call Transcript
— JNJ Earnings Call Transcript
—Q4 FY2025JNJ Q4 FY2025 Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology immunology neuroscience pulmonary-hypertension infectious-diseases-(hiv/aids) cardiovascular-and-metabolism electrophysiology mechanical-circulatory-support orthopaedics surgery vision-care

Company Identity

CIK0000200406
TickerJNJ
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedNJ
Websitehttps://www.jnj.com
Listed1944-09-25

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6c22e0acb42dab004a60e4a9c275b45c2e23cd9f4eada7eacdca85015ca0ebc7
parent: abcf5b71ada455a5c8db1821e6ff0d1f8b95af94f4b7bb7175da22798c62f378
content hash: 1fe3bddee085210b5e70f923a4caca23697e20ce7affce615225b7936a0bb729
signed: 2026-06-02T19:01:36.021Z
sources: 27 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf